Laura A Sena

11PUBLICATIONS
107CO-AUTHORS
Immunogenetics (incl. genetic immunology)Peripheral nervous systemMolecular targetsPredictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 01, 2026
HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer.

|Feb 19, 2026
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing Testing.

Madelyn F Klugman, Hua-Ling Tsai, Yasaman Iranmanesh

|Nov 21, 2025
Androgen Receptor Drives Polyamine Synthesis, Creating a Vulnerability for Prostate Cancer.

Rajendra Kumar, Sheila Jonnatan, David E Sanin

|Oct 26, 2025
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer.

Pornlada Likasitwatanakul, Carissa Besonen, Alexander K Tsai

|Oct 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.

David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching

|Dec 02, 2024
Intratumoral heterogeneity drives acquired therapy resistance in a patient with metastatic prostate cancer.

Dena P Rhinehart, Jiaying Lai, David E Sanin

Pageof 2

Frequent Collaborators

4 joint publications

Emmanuel S Antonarakis

3 joint publications

Mark C Markowski

3 joint publications

Tamara L Lotan

2 joint publications

Catherine H Marshall